Radiation

Home » Radiation

Video: Dr. Gerard Morton, “Radiation and Hormone Therapy”

Videos, Awareness Nights, Hormone Therapy, Radiation / By / / 1 minute of reading

July 2015 Scotiabank Awareness Night   Radiation and Hormone Therapy Dr. Gerard Morton, MB BCh BAO, MRCPI, FRCPC, FFRRCSI Associate Professor , Department of Radiation Oncology, University of Toronto Radiation Oncologist, Sunnybrook Odette Cancer Centre Head of Brachytherapy, Sunnybrook Odette Cancer Centre Chair,  Ontario Association of Radiation Oncologists Affiliate scientist, Evaluative Clinical Sciences, Odette Cancer Research Program, Sunnybrook Research Institute   CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 43:11 minutes

Video: Dr. Gerard Morton, “Radiation and Hormone Therapy” Read More »

Long-term ADT Best for Locally Advanced Prostate Cancer

Treatments, Hormone Therapy, Radiation / By / / 1 minute of reading

Continuation of androgen deprivation therapy for an additional 24 months improves all disease end points during 15 years of follow-up compared with short-term androgen deprivation in men with locally advanced prostate cancer treated with radiotherapy. Read the article.

Long-term ADT Best for Locally Advanced Prostate Cancer Read More »

Combining Radiotherapy With Anti-Androgen Improves Prostate Cancer Survival

Treatments, Hormone Therapy, Radiation / By / / 1 minute of reading

The addition of hormonal therapy to salvage radiotherapy demonstrated a significant survival benefit in patients with prostate cancer recurrence after radical prostatectomy, according to long-term follow-up data from a randomized trial. Read the article.

Combining Radiotherapy With Anti-Androgen Improves Prostate Cancer Survival Read More »

Some Prostate Cancer Patients May Not Benefit From Hormone Therapy

Treatments, Hormone Therapy, Radiation / By / / 1 minute of reading

Men with prostate cancer who also have had a heart attack may fare better with radiation therapy alone rather than with the standard treatment of radiation plus hormone therapy, a new analysis suggests. Over an average of 17 years of follow-up, men with high-risk prostate cancer who also had a heart condition lived longer after radiation treatment alone than similar men who had radiation and hormone therapy. Men who didn’t have heart problems lived longer if they had both treatments, the researchers added. Read the article.

Some Prostate Cancer Patients May Not Benefit From Hormone Therapy Read More »

Toronto hospital tests new, high-precision method of prostate cancer treatment

Radiation / By / / 1 minute of reading

Doctors at Toronto’s Sunnybrook Hospital are exploring a new, more precise way of administering radiation therapy to patients with prostate cancer. Stereotactic ablative body radiotherapy, or SABR, allows doctors to give patients a high dose of radiation in a short period of time, replacing the long hours of treatment commonly associated with radiation therapy. “What’s really revolutionary about this is that patients used to have to come for up to eight weeks of radiotherapy — one treatment per day, five days a week,” said Sunnybrook oncologist Andrew Loblaw. “Now with this new trial, we’ve been able to show that you

Toronto hospital tests new, high-precision method of prostate cancer treatment Read More »

Evolution of hypofractionated accelerated radiotherapy for prostate cancer – The Sunnybrook experience

Radiation / By / / 1 minute of reading

Stereotactic ablative body radiotherapy (SABR) is a newer method of ultra hypo fractionated radiotherapy that uses combination of image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT) or volumetric modulated arc therapy (VMAT), to deliver high doses of radiation in a few fractions to a target, at the same time sparing the surrounding organs at risk (OAR). Read this rather technical article. (Free UroToday login required.)

Evolution of hypofractionated accelerated radiotherapy for prostate cancer – The Sunnybrook experience Read More »

Good Prostate Cancer Outcomes Possible Despite Salvage Radiation Failure

Radiation, Radical Prostatectomy / By / / 1 minute of reading

Salvage radiation therapy (SRT) given after radical prostatectomy may improve outcomes in prostate cancer (PCa) patients, even in those who fail the treatment, according to study findings presented at the 56th annual meeting of the American Society for Radiation Oncology in San Francisco. Read the article.

Good Prostate Cancer Outcomes Possible Despite Salvage Radiation Failure Read More »

Aspirin Eases Genitourinary Toxicity from Prostate Cancer Radiotherapy

Radiation, Supplements / By / / 1 minute of reading

Low-dose aspirin use is independently associated with decreased acute genitourinary (GU) toxicity in patients undergoing radiotherapy for prostate cancer (PCa), researchers reported at the American Society for Radiation Oncology 56th annual meeting in San Francisco. Read the article.

Aspirin Eases Genitourinary Toxicity from Prostate Cancer Radiotherapy Read More »

VIDEO: Dr. Andrew Loblaw, “Image-Guided Diagnosis and Treatment- The Future of Prostate Cancer has Arrived!”

Videos, Awareness Nights, Radiation / By / / 1 minute of reading

  May 2014 Scotiabank Awareness Night “Image-Guided Diagnosis and Treatment- The Future of Prostate Cancer has Arrived!” Dr. Andrew Loblaw   MD, MSc, FRCSC Sunnybrook Health Sciences Centre Staff Radiation Oncologist, Odette Cancer Centre Associate Professor, Department of Radiation Oncology, University of Toronto Associate Professor, Department of Health Policy, Management and Evaluation, University of Toronto Courtesy Staff, Department of Surgery, North York General Hospital   Surgical Oncology, Division of Urology, University Health Network   Dr. Loblaw reviews the advantages of Magnetic Resonance Imaging (MRI) in the diagnosis and treatment of prostate cancer and the outcomes of image-guided radiation treatment for prostate cancer. He discusses the

VIDEO: Dr. Andrew Loblaw, “Image-Guided Diagnosis and Treatment- The Future of Prostate Cancer has Arrived!” Read More »

Scroll to Top